Company Filing History:
Years Active: 1996
Title: Yoshiro Ohtani: Innovator in Fibroblast Growth Factor Stabilization
Introduction
Yoshiro Ohtani is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of biochemistry, particularly in the stabilization of fibroblast growth factors, which are crucial for various biomedical applications. With one patent to his name, Ohtani's work highlights the intersection of innovation and practical healthcare solutions.
Latest Patents
Ohtani holds a patent for a composition of a stabilized fibroblast growth factor. This innovative composition incorporates an aluminum salt of cyclodextrin sulfate to stabilize the fibroblast growth factor (FGF). The stabilization process allows for the formulation of FGF in a reliable and effective manner, offering potential advancements in therapeutic applications.
Career Highlights
Ohtani currently works at Kaken Pharmaceutical Company, Ltd., where he focuses on developing new pharmaceutical formulations that leverage his research on fibroblast growth factors. His dedication to improving drug formulations has positioned him as a key player in the pharmaceutical industry.
Collaborations
Throughout his career, Ohtani has collaborated with talented professionals in his field, including Kazuhiro Fukunaga and Shigeki Hijikata. These partnerships have facilitated the advancement of research and innovation within Kaken Pharmaceutical, driving forward the company's mission to enhance patient care through effective pharmaceutical products.
Conclusion
Yoshiro Ohtani's contributions to the stabilization of fibroblast growth factors are a testament to his inventive spirit and commitment to healthcare innovation. As he continues his work at Kaken Pharmaceutical Company, his research will likely pave the way for new and improved therapeutic solutions in the future.